摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

1-溴-3-(3-甲氧基苯基)丙酮 | 20772-11-6

中文名称
1-溴-3-(3-甲氧基苯基)丙酮
中文别名
——
英文名称
1-bromo-3-((3-methoxy)phenyl)acetone
英文别名
1-Brom-3-(3-methoxy-phenyl)-aceton;1-Bromo-3-(3-methoxyphenyl)propan-2-one
1-溴-3-(3-甲氧基苯基)丙酮化学式
CAS
20772-11-6
化学式
C10H11BrO2
mdl
——
分子量
243.1
InChiKey
QYCJGDBVWSEHGX-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

物化性质

  • 沸点:
    130-135 °C(Press: 2 Torr)
  • 密度:
    1.404±0.06 g/cm3(Predicted)

计算性质

  • 辛醇/水分配系数(LogP):
    2.4
  • 重原子数:
    13
  • 可旋转键数:
    4
  • 环数:
    1.0
  • sp3杂化的碳原子比例:
    0.3
  • 拓扑面积:
    26.3
  • 氢给体数:
    0
  • 氢受体数:
    2

上下游信息

  • 上游原料
    中文名称 英文名称 CAS号 化学式 分子量
  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    carbamothioyl-D-phenylalanine1-溴-3-(3-甲氧基苯基)丙酮N,N-二甲基甲酰胺 为溶剂, 以91%的产率得到(R)-2-((4-(3-methoxybenzyl)thiazol-2-yl)amino)-3-phenylpropanoic acid
    参考文献:
    名称:
    Design, synthesis, SAR and biological investigation of 3-(carboxymethyl)rhodanine and aminothiazole inhibitors of Mycobacterium tuberculosis Zmp1
    摘要:
    Sixteen 3-(carboxymethyl)rhodanines, and twelve aminothiazoles as rhodanine-mimetics were designed, synthesized and tested as inhibitors of the Zmp1 enzyme from Mycobacterium tuberculosis (Mtb). Almost all rhodanines (5a-d, 5f-n, and 7a-b) exhibited Zmp1 inhibition with IC50 values in the range 1.3-43.9 mu M, whereas only aminothiazoles 12b and 12d proved active with IC50 values of 41.3 and 35.7 mu M, respectively. Structure-activity relationships (SAR) were coupled with molecular modeling studies to highlight structural determinants for Zmp1 inhibition. Moreover, rhodanines 5a and 5c induced 23.4 and 53.8% of Mtb growth inhibition in THP-1 infected cells, respectively, at the non-toxic concentration of 10 mu g/ml. This work represents a step forward in targeting Zmp1 by small molecules. (C) 2018 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2018.01.031
  • 作为产物:
    描述:
    3-甲氧基苯基乙酰氯氢溴酸 作用下, 以 乙腈 为溶剂, 反应 3.0h, 生成 1-溴-3-(3-甲氧基苯基)丙酮
    参考文献:
    名称:
    Design, synthesis, SAR and biological investigation of 3-(carboxymethyl)rhodanine and aminothiazole inhibitors of Mycobacterium tuberculosis Zmp1
    摘要:
    Sixteen 3-(carboxymethyl)rhodanines, and twelve aminothiazoles as rhodanine-mimetics were designed, synthesized and tested as inhibitors of the Zmp1 enzyme from Mycobacterium tuberculosis (Mtb). Almost all rhodanines (5a-d, 5f-n, and 7a-b) exhibited Zmp1 inhibition with IC50 values in the range 1.3-43.9 mu M, whereas only aminothiazoles 12b and 12d proved active with IC50 values of 41.3 and 35.7 mu M, respectively. Structure-activity relationships (SAR) were coupled with molecular modeling studies to highlight structural determinants for Zmp1 inhibition. Moreover, rhodanines 5a and 5c induced 23.4 and 53.8% of Mtb growth inhibition in THP-1 infected cells, respectively, at the non-toxic concentration of 10 mu g/ml. This work represents a step forward in targeting Zmp1 by small molecules. (C) 2018 Elsevier Ltd. All rights reserved.
    DOI:
    10.1016/j.bmcl.2018.01.031
点击查看最新优质反应信息

文献信息

  • NOVEL MACROCYCLIC INHIBITORS OF HEPATITIS C VIRUS REPLICATION
    申请人:Buckman Brad
    公开号:US20110081315A1
    公开(公告)日:2011-04-07
    The embodiments provide compounds of the general Formulae I, Ia, II, III, IV, V, VI-1, VI-2, VII, VIII, IX, X, XI, and XII, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.
    本实施例提供了一般式I、Ia、II、III、IV、V、VI-1、VI-2、VII、VIII、IX、X、XI和XII的化合物,以及包括药物组合物在内的组合物。本实施例还提供了治疗方法,包括治疗丙型肝炎病毒感染的方法和治疗肝纤维化的方法,这些方法通常涉及向需要该化合物或组合物的个体施用有效量的该化合物或组合物。
  • Fine mapping of the rice bacterial blight resistance gene Xa-4 and its co-segregation marker
    作者:Wenming Wang、Yongli Zhou、Guanhuai Jiang、Bojun Ma、Xuewei Chen、Qi Zhang、Lihuang Zhu、Wenxue Zhai
    DOI:10.1007/bf02886266
    日期:2000.10
    An F-2 population developed from the Xa-4 near isogenic lines, IR24 and IRBB4, was used for fine mapping of the rice bacterial blight resistance gene, Xa-4. Some restriction fragment length polymorphism (RFLP) markers on the high-density map constructed by Harushima et at. and the amplified DNA fragments homologous to the conserved domains of plant disease resistance (R) genes were used to construct the genetic linkage map around the gene Xa-4 by scoring susceptible individuals in the population. Xa-4 was mapped between the RFLP marker G181 and the polymerase chain reaction (PCR) marker M55. The R gene homologous fragment marker RS13 was found co-segregating with Xa-4 by analyzing all the plants in the population. This result opened an approach to map-based cloning of this gene, and marker RS13 can be applied to molecular marker-assisted selection of Xa-4 in rice breeding programs.
  • [EN] CYCLIC PEPTIDE INHIBITORS OF HEPATITIS C VIRUS REPLICATION<br/>[FR] INHIBITEURS PEPTIQUES CYCLIQUES DE LA RÉPLICATION DU VIRUS DE L'HÉPATITE C
    申请人:INTERMUNE INC
    公开号:WO2011038293A1
    公开(公告)日:2011-03-31
    The embodiments provide compounds of the general Formulae I, Ia, II, III, IV, V, VI-1, VI-2, VII, VIII, IX, X, XI, and XII, as well as compositions, including pharmaceutical compositions, comprising a subject compound. The embodiments further provide treatment methods, including methods of treating a hepatitis C virus infection and methods of treating liver fibrosis, the methods generally involving administering to an individual in need thereof an effective amount of a subject compound or composition.
查看更多

同类化合物

(R)-3-(叔丁基)-4-(2,6-二异丙氧基苯基)-2,3-二氢苯并[d][1,3]氧杂磷杂环戊烯 (2S,3R)-3-(叔丁基)-2-(二叔丁基膦基)-4-甲氧基-2,3-二氢苯并[d][1,3]氧杂磷杂戊环 (2S,2''S,3S,3''S)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2R,2''R,3R,3''R)-3,3''-二叔丁基-4,4''-二甲氧基-2,2'',3,3''-四氢-2,2''-联苯并[d][1,3]氧杂磷杂戊环 (2-氟-3-异丙氧基苯基)三氟硼酸钾 (+)-6,6'-{[(1R,3R)-1,3-二甲基-1,3基]双(氧)}双[4,8-双(叔丁基)-2,10-二甲氧基-丙二醇 麦角甾烷-6-酮,2,3,22,23-四羟基-,(2a,3a,5a,22S,23S)- 鲁前列醇 顺式6-(对甲氧基苯基)-5-己烯酸 顺式-铂戊脒碘化物 顺式-四氢-2-苯氧基-N,N,N-三甲基-2H-吡喃-3-铵碘化物 顺式-4-甲氧基苯基1-丙烯基醚 顺式-2,4,5-三甲氧基-1-丙烯基苯 顺式-1,3-二甲基-4-苯基-2-氮杂环丁酮 非那西丁杂质7 非那西丁杂质3 非那西丁杂质22 非那西丁杂质18 非那卡因 非布司他杂质37 非布司他杂质30 非布丙醇 雷诺嗪 阿达洛尔 阿达洛尔 阿莫噁酮 阿莫兰特 阿维西利 阿索卡诺 阿米维林 阿立酮 阿曲汀中间体3 阿普洛尔 阿普斯特杂质67 阿普斯特中间体 阿普斯特中间体 阿托西汀EP杂质A 阿托莫西汀杂质24 阿托莫西汀杂质10 阿托莫西汀EP杂质C 阿尼扎芬 阿利克仑中间体3 间苯胺氢氟乙酰氯 间苯二酚二缩水甘油醚 间苯二酚二异丙醇醚 间苯二酚二(2-羟乙基)醚 间苄氧基苯乙醇 间甲苯氧基乙酸肼 间甲苯氧基乙腈 间甲苯异氰酸酯